These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 8057666

  • 1. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells.
    Baker SJ, Pawlita M, Leutz A, Hoelzer D.
    Leukemia; 1994 Aug; 8(8):1309-17. PubMed ID: 8057666
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 5. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease.
    Bianchi Scarrà GL, Romani M, Coviello DA, Garrè C, Ravazzolo R, Vidali G, Ajmar F.
    Cancer Res; 1986 Dec; 46(12 Pt 1):6327-32. PubMed ID: 3536078
    [Abstract] [Full Text] [Related]

  • 6. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL, Wu RT.
    Cancer Res; 1994 Apr 15; 54(8):2192-8. PubMed ID: 7513611
    [Abstract] [Full Text] [Related]

  • 7. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
    Watanabe T, Mitchell T, Sariban E, Sabbath K, Griffin J, Kufe D.
    Mol Pharmacol; 1985 Jun 15; 27(6):683-8. PubMed ID: 3858662
    [Abstract] [Full Text] [Related]

  • 8. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
    Tonini GP, Radzioch D, Gronberg A, Clayton M, Blasi E, Benetton G, Varesio L.
    Cancer Res; 1987 Sep 01; 47(17):4544-7. PubMed ID: 3476195
    [Abstract] [Full Text] [Related]

  • 9. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
    Marazzi L, Parodi MT, Di Martino D, Ferrari S, Tonini GP.
    Anticancer Res; 1991 Sep 01; 11(2):947-52. PubMed ID: 2064352
    [Abstract] [Full Text] [Related]

  • 10. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
    Schaefer A, Dressel A, Lingelbach K, Schmidt CA, Steinheider G, Marquardt H.
    Leukemia; 1992 Aug 01; 6(8):828-33. PubMed ID: 1640736
    [Abstract] [Full Text] [Related]

  • 11. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y, Makishima M, Kanatani Y, Kasukabe T, Honma Y.
    Exp Hematol; 1996 May 01; 24(6):682-9. PubMed ID: 8635523
    [Abstract] [Full Text] [Related]

  • 12. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y, Onozuka Y, Okabe-Kado J, Kasukabe T, Hozumi M.
    Cancer Res; 1991 Sep 01; 51(17):4535-8. PubMed ID: 1873797
    [Abstract] [Full Text] [Related]

  • 13. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM, Miyazaki K, Takeyama H, Sherman ML, Spriggs DR, Carney WP, Kufe DW.
    Cancer Commun; 1989 Sep 01; 1(3):191-7. PubMed ID: 2639729
    [Abstract] [Full Text] [Related]

  • 14. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells.
    Mitchell T, Sariban E, Kufe D.
    Mol Pharmacol; 1986 Oct 01; 30(4):398-402. PubMed ID: 3531806
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
    Ogawa K, Tashima M, Toi T, Sawai H, Sawada H, Fujita J, Maruyama Y, Okuma M.
    Exp Hematol; 1994 Jan 01; 22(1):45-51. PubMed ID: 7506674
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells.
    Gómez-Casares MT, Delgado MD, Lerga A, Crespo P, Quincoces AF, Richard C, León J.
    Leukemia; 1993 Nov 01; 7(11):1824-33. PubMed ID: 8231250
    [Abstract] [Full Text] [Related]

  • 17. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
    Bar-Ner M, Messing LT, Cultraro CM, Birrer MJ, Segal S.
    Cell Growth Differ; 1992 Mar 01; 3(3):183-90. PubMed ID: 1633109
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M, Boss GR, Pascual FE, Pilz RB.
    Cell Growth Differ; 1995 Dec 01; 6(12):1559-66. PubMed ID: 9019161
    [Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of a K562 cell line resistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction.
    Biancha Scarrà G, Fiorentini P, Gambari R, Nastruzzi C, Barbieri R, Sessarego M, Ravazzolo R, Garrè C.
    Exp Hematol; 1989 Sep 01; 17(8):859-64. PubMed ID: 2475359
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effect of recombinant human leukemia inhibitory factor (LIF) and 1-beta-D-arabinofuranosylcytosine (Ara-C) on proto-oncogene expression and induction of differentiation in human U 937 cells.
    Brach MA, Riedel D, Mertelsmann RH, Herrmann F.
    Leukemia; 1990 Sep 01; 4(9):646-9. PubMed ID: 2144331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.